| 000 | 01754 a2200457 4500 | ||
|---|---|---|---|
| 005 | 20250516041410.0 | ||
| 264 | 0 | _c20111003 | |
| 008 | 201110s 0 0 eng d | ||
| 022 | _a1742-2094 | ||
| 024 | 7 |
_a10.1186/1742-2094-8-62 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aKim, Ji-Eun | |
| 245 | 0 | 0 |
_aP2X7 receptor activation ameliorates CA3 neuronal damage via a tumor necrosis factor-α-mediated pathway in the rat hippocampus following status epilepticus. _h[electronic resource] |
| 260 |
_bJournal of neuroinflammation _cJun 2011 |
||
| 300 |
_a62 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAcetamides _xpharmacology |
| 650 | 0 | 4 |
_aAdenosine Triphosphate _xanalogs & derivatives |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aCA3 Region, Hippocampal _xcytology |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMuscarinic Agonists _xpharmacology |
| 650 | 0 | 4 |
_aNeurons _xdrug effects |
| 650 | 0 | 4 |
_aPilocarpine _xpharmacology |
| 650 | 0 | 4 |
_aPurinergic Agonists _xpharmacology |
| 650 | 0 | 4 |
_aPurinergic Antagonists _xpharmacology |
| 650 | 0 | 4 |
_aPyridines _xpharmacology |
| 650 | 0 | 4 |
_aQuinolines _xpharmacology |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 | _aRats, Sprague-Dawley |
| 650 | 0 | 4 |
_aReceptors, Purinergic P2X7 _xmetabolism |
| 650 | 0 | 4 |
_aSignal Transduction _xphysiology |
| 650 | 0 | 4 |
_aStatus Epilepticus _xchemically induced |
| 650 | 0 | 4 |
_aTetrazoles _xpharmacology |
| 650 | 0 | 4 |
_aTranscription Factor RelA _xmetabolism |
| 650 | 0 | 4 |
_aTumor Necrosis Factor-alpha _xmetabolism |
| 700 | 1 | _aRyu, Hea Jin | |
| 700 | 1 | _aKang, Tae-Cheon | |
| 773 | 0 |
_tJournal of neuroinflammation _gvol. 8 _gp. 62 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1186/1742-2094-8-62 _zAvailable from publisher's website |
| 999 |
_c20891305 _d20891305 |
||